Bank of Montreal’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,933
Closed -$225 4172
2022
Q2
$225 Sell
3,933
-2,618
-40% -$144K ﹤0.01% 3196
2022
Q1
$410K Buy
6,551
+461
+8% +$30.4K ﹤0.01% 2980
2021
Q4
$622K Sell
6,090
-1,317
-18% -$116K ﹤0.01% 2233
2021
Q3
$671K Sell
7,407
-5,833
-44% -$530K ﹤0.01% 2709
2021
Q2
$1.27M Sell
13,240
-30,506
-70% -$2.44M ﹤0.01% 2336
2021
Q1
$3.73M Sell
43,746
-16,220
-27% -$1.67M ﹤0.01% 1489
2020
Q4
$3.72M Buy
59,966
+20,943
+54% +$875K ﹤0.01% 1540
2020
Q3
$1.74M Sell
39,023
-178,631
-82% -$5.59M ﹤0.01% 1719
2020
Q2
$4.26M Sell
217,654
-77,412
-26% -$1.19M ﹤0.01% 1238
2020
Q1
$2.96M Buy
295,066
+241,131
+447% +$3.36M ﹤0.01% 1237
2019
Q4
$696K Buy
+53,935
New +$641K ﹤0.01% 2479
2016
Q4
Sell
-10,000
Closed -$92K 4092
2016
Q3
$92K Buy
+10,000
New +$92K ﹤0.01% 2823

Other funds holding FLGT

Bank of Montreal's FLGT Position: Q3 2022 in Review

Bank of Montreal sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 3,933 shares — an estimated $225 sold.

Bank of Montreal first reported a position in FLGT in Q3 2016 and held it in 12 quarters. The position peaked at $4.26M in Q2 2020. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Bank of Montreal reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 3,933 Fulgent Genetics shares in Q3 2022, an estimated $225.
  • Bank of Montreal first reported a position in Fulgent Genetics in Q3 2016 and held it in 12 quarters.
  • Bank of Montreal's Fulgent Genetics position peaked at $4.26M in Q2 2020.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.